Skip to content

SION SION EBITDA

EBITDA at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
-$12.88M+49.5%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$700.54M-3,350%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-$134.51M+6.1%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
AbbVie logo
AbbVieABBV
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

$29.6Mebit+
$154.0KDepreciation Depletion & Amortization
=-$29.45M

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's EBITDA?
SION (SION) reported EBITDA of -$29.45M in Q1 2026.
How has SION's EBITDA changed year-over-year?
SION's EBITDA decreased by 51.0% year-over-year, from -$19.5M to -$29.45M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.